← Back to directory

Joan Clària

Researcher Next ID · RN-035405

Researcher · Medicine

Hôpital Beaujon

Clichy, Spain

Accepting doctoral researchersFunding unknown
Works count
712
Citation count
28,172
H-index
79
i10-index
253

Research interests

Medicine
Physics and Astronomy
Stellar, planetary, and galactic studies
Astronomy and Astrophysical Research
Liver Disease and Transplantation
Astrophysics and Star Formation Studies
Liver Disease Diagnosis and Treatment

Publications

  • Pathophysiology of decompensated cirrhosis: Portal hypertension, circulatory dysfunction, inflammation, metabolism and mitochondrial dysfunction

    Journal of Hepatology · 2021 · 10.1016/j.jhep.2021.01.002

  • The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology

    Journal of Hepatology · 2020 · https://doi.org/10.1016/j.jhep.2020.06.013

  • The systemic inflammation hypothesis: Towards a new paradigm of acute decompensation and multiorgan failure in cirrhosis

    Journal of Hepatology · 2020 · https://doi.org/10.1016/j.jhep.2020.11.048

  • Albumin in decompensated cirrhosis: new concepts and perspectives

    Gut · 2020 · https://doi.org/10.1136/gutjnl-2019-318843

  • PREDICT identifies precipitating events associated with the clinical course of acutely decompensated cirrhosis

    Journal of Hepatology · 2020 · https://doi.org/10.1016/j.jhep.2020.11.019

  • Effects of Albumin Treatment on Systemic and Portal Hemodynamics and Systemic Inflammation in Patients With Decompensated Cirrhosis

    Gastroenterology · 2019 · 10.1053/j.gastro.2019.03.021

  • Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLF

    Journal of Hepatology · 2019 · https://doi.org/10.1016/j.jhep.2019.11.009

  • Systemic inflammation in decompensated cirrhosis: Characterization and role in acute‐on‐chronic liver failure

    Hepatology · 2016 · https://doi.org/10.1002/hep.28740

  • Inhibition of soluble epoxide hydrolase modulates inflammation and autophagy in obese adipose tissue and liver: Role for omega-3 epoxides

    Proceedings of the National Academy of Sciences · 2014 · 10.1073/pnas.1422590112

  • Resolvins, Specialized Proresolving Lipid Mediators, and Their Potential Roles in Metabolic Diseases

    Cell Metabolism · 2013 · 10.1016/j.cmet.2013.10.006

  • Resolvin D1 and Resolvin D2 Govern Local Inflammatory Tone in Obese Fat

    The Journal of Immunology · 2012 · 10.4049/jimmunol.1201272

  • VVV DR1 : the first data release of the Milky Way bulge and southern plane from the near-infrared ESO public survey VISTA variables in the Vía Láctea

    Americanae (AECID Library) · 2012

  • VVV DR1 : the first data release of the Milky Way bulge and southern plane from the near-infrared ESO public survey VISTA variables in the Vía Láctea

    Americanae (AECID Library) · 2012

  • Resolvin D1 and Its Precursor Docosahexaenoic Acid Promote Resolution of Adipose Tissue Inflammation by Eliciting Macrophage Polarization toward an M2-Like Phenotype

    The Journal of Immunology · 2011 · 10.4049/jimmunol.1100225

  • Role for PPARγ in obesity‐induced hepatic steatosis as determined by hepatocyte‐ and macrophage‐specific conditional knockouts

    The FASEB Journal · 2011 · 10.1096/fj.10-173716

  • Obesity‐induced insulin resistance and hepatic steatosis are alleviated by ω‐3 fatty acids: a role for resolvins and protectins

    The FASEB Journal · 2009 · 10.1096/fj.08-125674

  • Docosahexaenoic acid (DHA) blunts liver injury by conversion to protective lipid mediators: protectin D1 and 17S‐hydroxy‐DHA

    The FASEB Journal · 2006 · 10.1096/fj.06-6250fje

  • Docosahexaenoic acid (DHA) blunts liver injury by conversion to protective lipid mediators: protectin D1 and 17S‐hydroxy‐DHA

    The FASEB Journal · 2006 · 10.1096/fj.06-6250fje

  • Cyclooxygenase‐2 and 5‐lipoxygenase converging functions on cell proliferation and tumor angiogenesis: implications for cancer therapy

    The FASEB Journal · 2003 · 10.1096/fj.03-0053rev

  • Cyclooxygenase-2 Biology

    Current Pharmaceutical Design · 2003 · 10.2174/1381612033454054

  • Endogenous cannabinoids: A new system involved in the homeostasis of arterial pressure in experimental cirrhosis in the rat

    Gastroenterology · 2002 · 10.1053/gast.2002.30305

  • Integrated UBV Photometry of 624 Star Clusters and Associations in the Large Magellanic Cloud

    The Astrophysical Journal Supplement Series · 1996 · 10.1086/192251

  • Aspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell-leukocyte interactions.

    Proceedings of the National Academy of Sciences · 1995 · 10.1073/pnas.92.21.9475

  • Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites

    Gastroenterology · 1993 · 10.1016/0016-5085(93)90031-7

  • Circulating levels of endothelin in cirrhosis

    Gastroenterology · 1993 · 10.1016/0016-5085(93)90360-o

Current projects

    No projects listed.